Skip to main content

Table 2 Age-adjusted and age group-specific 5-year relative survival (RS) for the period 2002-2006 by histologic subtypes of endometrial cancer patients diagnosed in Germany, 1997-2006a

From: Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage

Histologic subtypes Overallb Age groups
    15-49 years 50-69 years 70+ years
  Count (%c) RS (SE) Count (%) RS (SE) Count (%) RS (SE) Count (%) RS (SE)
Overall 30,906 (100) 81.0 (0.4) 1,949 (6) 90.0 (1.0) 15,995 (52) 84.8 (0.4) 12,962 (42) 74.8 (0.8)
Adenocarcinoma 28,273 (91.5) 83.9 (0.4) 1,578 (6) 92.6 (1.0) 14,748 (52) 87.6 (0.4) 11,947 (42) 77.8 (0.8)
   Adenocarcinoma, NOS 10,427 (33.7) 84.7 (0.7) 606 (6) 93.5 (1.5) 5,353 (51) 88.7 (0.7) 4,468 (43) 78.1 (1.3)
   Papillary 1,141 (3.7) 68.4 (2.4) 50 (4)   547 (48) 77.2 (2.7) 544 (48) 57.3 (3.8)
   Clear cell 330 (1.1) 62.0 (4.3) 8 (2)   140 (43)   182 (55)  
   Squamous metaplasia 686 (2.2) 94.3 (2.5) 65 (9) 95.2 (3.9) 375 (55) 92.3 (2.4) 246 (36) 94.1 (4.9)
   Mucinous 268 (0.9) 85.2 (4.1) 12 (5)   130 (48) 93.4 (3.9) 126 (47)  
   Adenosquamous 857 (2.8) 75.0 (2.5) 57 (7)   453 (53) 80.1 (2.9) 347 (40) 64.3 (4.8)
   Endometrioid 13,650 (44.2) 86.0 (0.7) 738 (5) 93.7 (1.4) 7,323 (54) 88.8 (0.6) 5,589 (41) 81.3 (1.3)
   Other adenocarcinomad 914 (2.9) 68.3 (2.5) 42 (4)   427 (47) 70.5 (3.3) 445 (49) 57.2 (4.4)
Carcinoma NOS 619 (2.0) 60.4 (3.3) 42 (7)   272 (44) 69.1 (4.4) 305 (49)  
Sarcoma 1,682 (5.4) 43.1 (1.8) 287 (17) 75.7 (3.8) 834 (50) 47.6 (2.4) 561 (33) 31.7 (3.3)
Others (mixture) e 332 (1.1) 47.3 (4.2) 42 (13)   141 (42)   149 (45)  
  1. Abbreviations: NOS = not otherwise specified; RS = point estimates of relative survival (%); SE = standard error (percent units);
  2. a unstable point estimates of RS (SE > 5 percent units) were not reported;
  3. b age-adjusted 5-year relative survival;
  4. c % of histologic subtypes;
  5. d including papillary serous adenocarcinomas (70 cases);
  6. e including other specified carcinomas (42 cases).